Effect of CYP2C19 polymorphisms on the clinical outcome of low-dose clobazam therapy in Japanese patients with epilepsy
Crossref DOI link: https://doi.org/10.1007/s00228-014-1773-z
Published Online: 2014-10-18
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hashi, Sachiyo
Yano, Ikuko
Shibata, Mai
Masuda, Satohiro
Kinoshita, Masako
Matsumoto, Riki
Ikeda, Akio
Takahashi, Ryosuke
Matsubara, Kazuo
Text and Data Mining valid from 2014-10-18